PortfoliosLab logo
NTRA vs. LLY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between NTRA and LLY is 0.40, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

NTRA vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Natera, Inc. (NTRA) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

NTRA:

1.03

LLY:

0.00

Sortino Ratio

NTRA:

2.07

LLY:

0.20

Omega Ratio

NTRA:

1.25

LLY:

1.03

Calmar Ratio

NTRA:

2.55

LLY:

-0.08

Martin Ratio

NTRA:

7.23

LLY:

-0.15

Ulcer Index

NTRA:

8.92%

LLY:

12.52%

Daily Std Dev

NTRA:

48.20%

LLY:

38.16%

Max Drawdown

NTRA:

-77.74%

LLY:

-68.27%

Current Drawdown

NTRA:

-11.14%

LLY:

-21.03%

Fundamentals

Market Cap

NTRA:

$21.38B

LLY:

$678.30B

EPS

NTRA:

-$1.54

LLY:

$12.27

PEG Ratio

NTRA:

0.00

LLY:

1.16

PS Ratio

NTRA:

11.73

LLY:

13.84

PB Ratio

NTRA:

17.33

LLY:

44.23

Total Revenue (TTM)

NTRA:

$1.83B

LLY:

$49.00B

Gross Profit (TTM)

NTRA:

$1.13B

LLY:

$40.03B

EBITDA (TTM)

NTRA:

-$170.27M

LLY:

$16.67B

Returns By Period

In the year-to-date period, NTRA achieves a -0.64% return, which is significantly higher than LLY's -1.96% return.


NTRA

YTD

-0.64%

1M

6.25%

6M

17.41%

1Y

49.39%

5Y*

27.48%

10Y*

N/A

LLY

YTD

-1.96%

1M

3.16%

6M

-8.93%

1Y

0.06%

5Y*

38.62%

10Y*

28.72%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NTRA vs. LLY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NTRA
The Risk-Adjusted Performance Rank of NTRA is 8888
Overall Rank
The Sharpe Ratio Rank of NTRA is 8484
Sharpe Ratio Rank
The Sortino Ratio Rank of NTRA is 8787
Sortino Ratio Rank
The Omega Ratio Rank of NTRA is 8383
Omega Ratio Rank
The Calmar Ratio Rank of NTRA is 9595
Calmar Ratio Rank
The Martin Ratio Rank of NTRA is 9191
Martin Ratio Rank

LLY
The Risk-Adjusted Performance Rank of LLY is 4545
Overall Rank
The Sharpe Ratio Rank of LLY is 5050
Sharpe Ratio Rank
The Sortino Ratio Rank of LLY is 4141
Sortino Ratio Rank
The Omega Ratio Rank of LLY is 4141
Omega Ratio Rank
The Calmar Ratio Rank of LLY is 4545
Calmar Ratio Rank
The Martin Ratio Rank of LLY is 4646
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

NTRA vs. LLY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Natera, Inc. (NTRA) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current NTRA Sharpe Ratio is 1.03, which is higher than the LLY Sharpe Ratio of 0.00. The chart below compares the historical Sharpe Ratios of NTRA and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

NTRA vs. LLY - Dividend Comparison

NTRA has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.71%.


TTM20242023202220212020201920182017201620152014
NTRA
Natera, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LLY
Eli Lilly and Company
0.71%0.67%0.78%1.07%1.23%1.75%1.96%1.95%2.46%2.77%2.37%2.84%

Drawdowns

NTRA vs. LLY - Drawdown Comparison

The maximum NTRA drawdown since its inception was -77.74%, which is greater than LLY's maximum drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for NTRA and LLY. For additional features, visit the drawdowns tool.


Loading data...

Volatility

NTRA vs. LLY - Volatility Comparison

The current volatility for Natera, Inc. (NTRA) is 12.41%, while Eli Lilly and Company (LLY) has a volatility of 21.88%. This indicates that NTRA experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

NTRA vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Natera, Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B12.00B14.00B20212022202320242025
501.83M
12.73B
(NTRA) Total Revenue
(LLY) Total Revenue
Values in USD except per share items

NTRA vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between Natera, Inc. and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%20212022202320242025
63.2%
82.5%
(NTRA) Gross Margin
(LLY) Gross Margin
NTRA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Natera, Inc. reported a gross profit of 317.22M and revenue of 501.83M. Therefore, the gross margin over that period was 63.2%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a gross profit of 10.50B and revenue of 12.73B. Therefore, the gross margin over that period was 82.5%.

NTRA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Natera, Inc. reported an operating income of -79.18M and revenue of 501.83M, resulting in an operating margin of -15.8%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported an operating income of 5.41B and revenue of 12.73B, resulting in an operating margin of 42.5%.

NTRA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Natera, Inc. reported a net income of -66.94M and revenue of 501.83M, resulting in a net margin of -13.3%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a net income of 2.76B and revenue of 12.73B, resulting in a net margin of 21.7%.